1. Home
  2. PRGO vs AGIO Comparison

PRGO vs AGIO Comparison

Compare PRGO & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$12.86

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$26.90

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRGO
AGIO
Founded
1887
2007
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
1991
2013

Fundamental Metrics

Financial Performance
Metric
PRGO
AGIO
Price
$12.86
$26.90
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$22.50
$32.13
AVG Volume (30 Days)
3.8M
2.7M
Earning Date
11-05-2025
10-30-2025
Dividend Yield
8.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,281,800,000.00
$44,791,000.00
Revenue This Year
N/A
$28.75
Revenue Next Year
N/A
$139.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.26
52 Week Low
$12.17
$22.24
52 Week High
$30.93
$46.00

Technical Indicators

Market Signals
Indicator
PRGO
AGIO
Relative Strength Index (RSI) 31.06 35.67
Support Level $12.93 $26.80
Resistance Level $13.63 $28.61
Average True Range (ATR) 0.45 1.15
MACD 0.25 0.28
Stochastic Oscillator 4.17 16.77

Price Performance

Historical Comparison
PRGO
AGIO

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: